| Literature DB >> 35069297 |
Hao Fong Sit1, Ieng Wai Hong2, Sebastian Burchert3, Elvo Kuai Long Sou4, Mek Wong4, Wen Chen5, Agnes Iok Fong Lam6, Brian J Hall7,8.
Abstract
Background: Chinese young adults experience barriers to mental health treatment, including the lack of treatment providers and stigma around treatment seeking. Evidence-based digital mental health interventions are promising and scalable alternatives to face-to-face treatment for this population, but lack rigorous evidence to support scale-up in China. Aim: The study was a feasibility study for a large-scale RCT of Step-by-Step, a behavioral activation-based, mental health intervention to address depression and anxiety symptoms in Chinese young adults. It sought to assess feasibility of recruitment and of delivery of Step-by-Step in a University setting, to assess acceptability of the intervention, and to examine potential effectiveness. Method: An uncontrolled, feasibility trial was conducted to assess the feasibility and acceptability of Chinese Step-by-Step for Chinese University students with elevated depressive symptoms (PHQ-9 scores at or above 10) in Macao, China. Data was collected at two different time points (i.e., baseline and 8-weeks after baseline), administered via questionnaires embedded in an interventional mobile application. Participation rate and dropout rate were measured. Depressive and anxiety symptom severity, well-being, and self-defined stress were assessed. Satisfaction with the program was assessed using qualitative interviews.Entities:
Keywords: Chinese young adults; depression; digital health; e-mental health; feasibility; minimally guided intervention
Year: 2022 PMID: 35069297 PMCID: PMC8777229 DOI: 10.3389/fpsyt.2021.812667
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1Study overview.
Figure 2Number of participants completing each session.
Participant characteristics at baseline (N = 38).
|
|
|
|
| |
|---|---|---|---|---|
|
|
|
|
| |
| Age (18-25, M, | 19.00 (0.91) | 20.14 (2.19) | 18.46 (0.66) | 18 (0) |
|
| ||||
| Male | 3 (7.9%) | 3 (7.9%) | 2 (5.3%) | 3 (7.9%) |
| Female | 10 (26.3%) | 4 (10.5%) | 12 (31.6%) | - |
|
| ||||
| Year 1 | 7 (20.5%) | 2 (5.3%) | 11 (28.9%) | 1 (2.6%) |
| Year 2 | 3 (7.9%) | 2 (5.3%) | 1 (2.6%) | - |
| Year 3 | 2 (5.3%) | 1 (2.6%) | 1 (2.6%) | - |
| Year 4 | 1 (2.6%) | 2 (5.3%) | - | - |
|
| ||||
| Yes | 6 (15.8%) | 2 (5.3%) | 5 (13.2%) | 1 (2.6%) |
| No | 7 (18.4%) | 5 (13.2%) | 8 (21.1%) | - |
|
| ||||
| Yes | 11 (28.9%) | 3 (7.9%) | 8 (21.1%) | 1 (2.6%) |
| No | 2 (7.7%) | 4 (10.5%) | 5 (13.2%) | - |
|
| ||||
| Residential fellow (RF) | 10 (26.3%) | 7 (18.4%) | 9 (23.7%) | 1 (2.6%) |
| Student counsellor/social worker | 1 (2.6%) | - | - | - |
| Friend | - | - | 2 (5.3%) | - |
| Organization/NGO | 1 (2.6%) | - | 1 (2.6%) | - |
| Others | 1 (2.6%) | - | 1 (2.6%) | - |
|
| ||||
| Yes | 1 (2.6%) | 3 (7.9%) | 1 (2.6%) | - |
| No | 12 (31.6%) | 4 (10.5%) | 11 (28.9%) | 1 (2.6%) |
|
| ||||
| Yes | - | - | - | |
| No | 13 (34.2%) | 7 (18.4%) | 12 (31.6%) | 1 (2.6%) |
|
| ||||
| Yes | 1 (2.6%) | - | - | - |
| No | 12 (31.6%) | 7 (18.4%) | 12 (31.6%) | 1 (2.6%) |
|
| ||||
| Yes | 1 (2.6%) | 1 (2.6%) | - | - |
| No | 12 (31.6%) | 6 (15.4%) | 12 (31.6%) | 1 (2.6%) |
Study outcome variables at baseline (N = 38).
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| PHQ-9 | 13.07 | 2.93 | 12.86 | 4.18 | 13.8 | 3.14 | 11 | 1 |
| GAD-7 | 9.85 | 4.08 | 10.00 | 4.16 | 10.55 | 4.41 | 14 | . |
| WHO-5 | 11.77 | 6.60 | 9.57 | 4.65 | 10.73 | 4.58 | 9 | . |
| PSYCHOLOPS | 12.31 | 5.19 | 13.00 | 2.71 | 13.00 | 2.00 | 15 | . |
PHQ-9, The Patient Health Questionnaire-9; GAD-7, The General Anxiety Disorder-7; WHO-5, The World Health Organization- Five Well-Being Index; PSYCHLOPS,The Psychological Outcome Profiles. In Non-starters, 11 participants completed GAD-7 and WHO-5, and 7 completed PSYCHOLOPS. Among those who self-excluded, 1 participant completed GAD-7, WHO-5 and PSYCHOLOPS.
Baseline and post-test changes among completers.
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| PHQ-9 | 13.08 | 3.06 | 5.83 | 5.84 | 4.29 | 11 | 0.001 | 0.26 | 1.24 |
| GAD-7 | 9.75 | 4.25 | 6.75 | 3.82 | 2.61 | 11 | 0.024 | 0.52 | 0.75 |
| WHO-5 | 12.5 | 6.32 | 14.25 | 5.77 | 1.34 | 11 | 0.208 | 0.72 | 0.39 |
| PSYCHOLOPS | 12 | 5.29 | 9.17 | 4.02 | 3.44 | 11 | 0.006 | 0.85 | 0.99 |
N = 12 (One completer did not answer post-test). PHQ-9, The Patient Health Questionnaire−9; GAD-7, The General Anxiety Disorder-7; WHO-5, The World Health Organization-Five Well-Being Index; PSYCHLOPS, the Psychological Outcome Profiles.
p < 0.05,
p < 0.01. Cohen's d: 0.2 (small), 0.5 (medium), 0.8 (large).
Means and SDs of clinical outcomes before and after intervention for control, partial completers and completers.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| PHQ-9 (M, SD) | 10 | 8 | 13.75 (4.5) | 6.75 (4.65) | 12.75 (2.38) | 5.48 (6.61) |
| GAD-7 (M, SD) | 8 | 12 | 11.25 (4.11) | 7.25 (3.5) | 9.00 (4.38) | 6.50 (4.17) |
| WHO-5 (M, SD) | 11 | 11 | 11.5 (1.0) | 11.75 (5.32) | 13.00 (7.84) | 15.50 (5.90) |
| PSYCHLOPS (M, SD) | 9 | 12 | 12.75 (4.5) | 10.75 (3.5) | 11.63 (5.90) | 8.38 (4.24) |
PHQ-9, The Patient Health Questionnaire−9; GAD-7, The General Anxiety Disorder-7; WHO-5, The World Health Organization-Five Well-Being Index; PSYCHLOPS, the Psychological Outcome Profiles.
Figure 3Mean PHQ-9 score in each week for all participants across 8 weeks.
Figure 4Mean PHQ-9 score in each week for participants who did some part of the intervention and completed post-assessment.